Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.19 USD | +3.07% | -1.30% | +168.50% |
09/05 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
29/04 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.50% | 113.61Cr | |
+26.03% | 4.92TCr | |
+0.92% | 4.21TCr | |
+49.90% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.28% | 2.61TCr | |
-22.21% | 1.87TCr | |
+8.81% | 1.33TCr | |
+32.25% | 1.23TCr | |
+0.39% | 1.2TCr |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : SVB Leerink Adjusts Price Target on Cullinan Management to $54 From $48, Maintains Outperform Rating